Replies to post #225845 on Biotech Values

[DewDiligence]

PTLA -39%/AH on soft 4Q19 Andexxa sales ($28M):

https://finance.yahoo.com/news/portola-announces-preliminary-full-2019-210100664.html

2019 full-year Andexxa sales were a mere $111M.

(I’m on record from way back that Andexxa would not be a big-selling drug.)